BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27984384)

  • 1. Mixing It Up: Coadministration of tPA/DNase in Complicated Parapneumonic Pleural Effusions and Empyema.
    Bishwakarma R; Shah S; Frank L; Zhang W; Sharma G; Nishi SP
    J Bronchology Interv Pulmonol; 2017 Jan; 24(1):40-47. PubMed ID: 27984384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
    Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
    Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
    Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
    Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rethinking the Doses of Tissue Plasminogen Activator and Deoxyribonuclease Administrated Concurrently for Intrapleural Therapy for Complicated Pleural Effusion and Empyema.
    Innabi A; Surana A; Alzghoul B; Meena N
    Cureus; 2018 Feb; 10(2):e2214. PubMed ID: 30755840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
    Khemasuwan D; Sorensen J; Griffin DC
    Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.
    Majid A; Kheir F; Folch A; Fernandez-Bussy S; Chatterji S; Maskey A; Fashjian M; Cheng G; Ochoa S; Alape D; Folch E
    Ann Am Thorac Soc; 2016 Sep; 13(9):1512-8. PubMed ID: 27333122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
    Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
    Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
    Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
    JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
    Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
    Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study.
    Fitzgerald DB; Muruganandan S; Tsim S; Ip H; Asciak R; Walker S; Uribe Becerra JP; Majid A; Ahmed L; Rahman NM; Maskell NA; Blyth KG; Lee YCG
    Respiration; 2021; 100(5):452-460. PubMed ID: 33784710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema.
    Smith D; Shaw H; Ryder T
    Intern Med J; 2023 Dec; 53(12):2313-2318. PubMed ID: 37029951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound grade correlation.
    James CA; Braswell LE; Pezeshkmehr AH; Roberson PK; Parks JA; Moore MB
    Pediatr Radiol; 2017 Jan; 47(1):89-95. PubMed ID: 27709281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination Tissue Plasminogen Activator and DNase for Loculated Malignant Pleural Effusions: A Single-center Retrospective Review.
    Chan C; Sekowski V; Zheng B; Li P; Stollery D; Veenstra J; Gillson AM
    J Bronchology Interv Pulmonol; 2023 Jul; 30(3):238-243. PubMed ID: 35698287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions.
    Weinstein M; Restrepo R; Chait PG; Connolly B; Temple M; Macarthur C
    Pediatrics; 2004 Mar; 113(3 Pt 1):e182-5. PubMed ID: 14993574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose.
    Popowicz N; Ip H; Lau EPM; Piccolo F; Dootson K; Yeoh C; Phu WY; Brown R; West A; Ahmed L; Lee YCG
    Respirology; 2022 Jul; 27(7):510-516. PubMed ID: 35441458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Stratification in Patients with Complicated Parapneumonic Effusions and Empyema Using the RAPID Score.
    Touray S; Sood RN; Lindstrom D; Holdorf J; Ahmad S; Knox DB; Sosa AF
    Lung; 2018 Oct; 196(5):623-629. PubMed ID: 30099584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
    Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
    J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. tPA/DNase for Complicated Parapneumonic Effusions and Empyemas.
    Maiga A; Pinkerman R; Deppen SA; Scruggs J; Mcguire P; Tarpley JL; Grogan EL
    Am Surg; 2017 Dec; 83(12):1458-1459. PubMed ID: 29336772
    [No Abstract]   [Full Text] [Related]  

  • 19. Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis.
    Yokoyama Y; Kuno T; Takagi H; Burfeind W
    Asian Cardiovasc Thorac Ann; 2023 Jun; 31(5):451-458. PubMed ID: 37287257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapleural tissue plasminogen activator for complicated pleural effusions.
    Skeete DA; Rutherford EJ; Schlidt SA; Abrams JE; Parker LA; Rich PB
    J Trauma; 2004 Dec; 57(6):1178-83. PubMed ID: 15625447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.